RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...
Along with the effectiveness against severe outcomes, "we were also able to show that the vaccines worked well in adults 75 ...
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...
A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...
In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
RSV poses a health threat to some older adults, prompting CDC's call for vaccination and Medicare's assurance of coverage of ...